RxDoctor Payments Data

Mary Cole

Adult Health · Tuscaloosa, ALNPI 1205861440

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.1% of the total across 343 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,546in general payments, 2019–2025

Across 343 payments — averaging $19.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Mallinckrodt Hospital Products Inc.$911
  • Amgen$752
  • UCB, Inc.$589
  • Johnson & Johnson$510
  • Novartis$435
  • plus $2K from 15 others

What the payments were for

  • Food & beverage$6,35497%
  • Education$1923%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,546 in reported general payments places this provider in the 90th percentile of 308 adult health providers in Alabama.

See all adult health providers in Alabama

Most prescribed under Part D

DrugClaimsCost to plans & patients
RinvoqUpadacitinib17$109,460
Hydroxychloroquine Sulfate109$5,894
Diclofenac Sodium50$1,756
MethotrexateMethotrexate Sodium68$1,725
Duloxetine Hcl36$686
Cyclobenzaprine Hcl13$292
Prednisone45$281
Nabumetone15$273
Tizanidine Hcl30$231
Allopurinol17$184
Meloxicam17$100

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRinvoq$1,299$109,46017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 308 adult health providers in Alabama.

Other adult health in Tuscaloosa

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →